Global Human Rabies Immunoglobulin (IM) Market Research Report 2024(Status and Outlook)

Global Human Rabies Immunoglobulin (IM) Market Research Report 2024(Status and Outlook)



Report Overview:

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.

Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization.

In this report, we study ERIG (Equine Rabies Immunoglobulin) and HRIG (Human Rabies Immunoglobulin)

The Global Human Rabies Immunoglobulin (IM) Market Size was estimated at USD 423.50 million in 2023 and is projected to reach USD 607.57 million by 2029, exhibiting a CAGR of 6.20% during the forecast period.

This report provides a deep insight into the global Human Rabies Immunoglobulin (IM) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Rabies Immunoglobulin (IM) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Rabies Immunoglobulin (IM) market in any manner.

Global Human Rabies Immunoglobulin (IM) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

CSL Behring

Grifols

Sanofi

Sichuan Yuanda Shuyang

CNBG

Kamada

CBPO

Shuanglin Bio

Weiguang Bio

Shanghai RAAS

Bharat Serum

VINS

Market Segmentation (by Type)

ERIG

HRIG

Market Segmentation (by Application)

Category II Exposure

Category III Exposure

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Human Rabies Immunoglobulin (IM) Market

Overview of the regional outlook of the Human Rabies Immunoglobulin (IM) Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Rabies Immunoglobulin (IM) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Human Rabies Immunoglobulin (IM)
1.2 Key Market Segments
1.2.1 Human Rabies Immunoglobulin (IM) Segment by Type
1.2.2 Human Rabies Immunoglobulin (IM) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Human Rabies Immunoglobulin (IM) Market Overview
2.1 Global Market Overview
2.1.1 Global Human Rabies Immunoglobulin (IM) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Human Rabies Immunoglobulin (IM) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Human Rabies Immunoglobulin (IM) Market Competitive Landscape
3.1 Global Human Rabies Immunoglobulin (IM) Sales by Manufacturers (2019-2024)
3.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Rabies Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Rabies Immunoglobulin (IM) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Rabies Immunoglobulin (IM) Sales Sites, Area Served, Product Type
3.6 Human Rabies Immunoglobulin (IM) Market Competitive Situation and Trends
3.6.1 Human Rabies Immunoglobulin (IM) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Rabies Immunoglobulin (IM) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Human Rabies Immunoglobulin (IM) Industry Chain Analysis
4.1 Human Rabies Immunoglobulin (IM) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Human Rabies Immunoglobulin (IM) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Human Rabies Immunoglobulin (IM) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2019-2024)
6.3 Global Human Rabies Immunoglobulin (IM) Market Size Market Share by Type (2019-2024)
6.4 Global Human Rabies Immunoglobulin (IM) Price by Type (2019-2024)
7 Human Rabies Immunoglobulin (IM) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Rabies Immunoglobulin (IM) Market Sales by Application (2019-2024)
7.3 Global Human Rabies Immunoglobulin (IM) Market Size (M USD) by Application (2019-2024)
7.4 Global Human Rabies Immunoglobulin (IM) Sales Growth Rate by Application (2019-2024)
8 Human Rabies Immunoglobulin (IM) Market Segmentation by Region
8.1 Global Human Rabies Immunoglobulin (IM) Sales by Region
8.1.1 Global Human Rabies Immunoglobulin (IM) Sales by Region
8.1.2 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region
8.2 North America
8.2.1 North America Human Rabies Immunoglobulin (IM) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Rabies Immunoglobulin (IM) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Rabies Immunoglobulin (IM) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 CSL Behring
9.1.1 CSL Behring Human Rabies Immunoglobulin (IM) Basic Information
9.1.2 CSL Behring Human Rabies Immunoglobulin (IM) Product Overview
9.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Product Market Performance
9.1.4 CSL Behring Business Overview
9.1.5 CSL Behring Human Rabies Immunoglobulin (IM) SWOT Analysis
9.1.6 CSL Behring Recent Developments
9.2 Grifols
9.2.1 Grifols Human Rabies Immunoglobulin (IM) Basic Information
9.2.2 Grifols Human Rabies Immunoglobulin (IM) Product Overview
9.2.3 Grifols Human Rabies Immunoglobulin (IM) Product Market Performance
9.2.4 Grifols Business Overview
9.2.5 Grifols Human Rabies Immunoglobulin (IM) SWOT Analysis
9.2.6 Grifols Recent Developments
9.3 Sanofi
9.3.1 Sanofi Human Rabies Immunoglobulin (IM) Basic Information
9.3.2 Sanofi Human Rabies Immunoglobulin (IM) Product Overview
9.3.3 Sanofi Human Rabies Immunoglobulin (IM) Product Market Performance
9.3.4 Sanofi Human Rabies Immunoglobulin (IM) SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Sichuan Yuanda Shuyang
9.4.1 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Basic Information
9.4.2 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product Overview
9.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product Market Performance
9.4.4 Sichuan Yuanda Shuyang Business Overview
9.4.5 Sichuan Yuanda Shuyang Recent Developments
9.5 CNBG
9.5.1 CNBG Human Rabies Immunoglobulin (IM) Basic Information
9.5.2 CNBG Human Rabies Immunoglobulin (IM) Product Overview
9.5.3 CNBG Human Rabies Immunoglobulin (IM) Product Market Performance
9.5.4 CNBG Business Overview
9.5.5 CNBG Recent Developments
9.6 Kamada
9.6.1 Kamada Human Rabies Immunoglobulin (IM) Basic Information
9.6.2 Kamada Human Rabies Immunoglobulin (IM) Product Overview
9.6.3 Kamada Human Rabies Immunoglobulin (IM) Product Market Performance
9.6.4 Kamada Business Overview
9.6.5 Kamada Recent Developments
9.7 CBPO
9.7.1 CBPO Human Rabies Immunoglobulin (IM) Basic Information
9.7.2 CBPO Human Rabies Immunoglobulin (IM) Product Overview
9.7.3 CBPO Human Rabies Immunoglobulin (IM) Product Market Performance
9.7.4 CBPO Business Overview
9.7.5 CBPO Recent Developments
9.8 Shuanglin Bio
9.8.1 Shuanglin Bio Human Rabies Immunoglobulin (IM) Basic Information
9.8.2 Shuanglin Bio Human Rabies Immunoglobulin (IM) Product Overview
9.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Product Market Performance
9.8.4 Shuanglin Bio Business Overview
9.8.5 Shuanglin Bio Recent Developments
9.9 Weiguang Bio
9.9.1 Weiguang Bio Human Rabies Immunoglobulin (IM) Basic Information
9.9.2 Weiguang Bio Human Rabies Immunoglobulin (IM) Product Overview
9.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Product Market Performance
9.9.4 Weiguang Bio Business Overview
9.9.5 Weiguang Bio Recent Developments
9.10 Shanghai RAAS
9.10.1 Shanghai RAAS Human Rabies Immunoglobulin (IM) Basic Information
9.10.2 Shanghai RAAS Human Rabies Immunoglobulin (IM) Product Overview
9.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Product Market Performance
9.10.4 Shanghai RAAS Business Overview
9.10.5 Shanghai RAAS Recent Developments
9.11 Bharat Serum
9.11.1 Bharat Serum Human Rabies Immunoglobulin (IM) Basic Information
9.11.2 Bharat Serum Human Rabies Immunoglobulin (IM) Product Overview
9.11.3 Bharat Serum Human Rabies Immunoglobulin (IM) Product Market Performance
9.11.4 Bharat Serum Business Overview
9.11.5 Bharat Serum Recent Developments
9.12 VINS
9.12.1 VINS Human Rabies Immunoglobulin (IM) Basic Information
9.12.2 VINS Human Rabies Immunoglobulin (IM) Product Overview
9.12.3 VINS Human Rabies Immunoglobulin (IM) Product Market Performance
9.12.4 VINS Business Overview
9.12.5 VINS Recent Developments
10 Human Rabies Immunoglobulin (IM) Market Forecast by Region
10.1 Global Human Rabies Immunoglobulin (IM) Market Size Forecast
10.2 Global Human Rabies Immunoglobulin (IM) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Rabies Immunoglobulin (IM) Market Size Forecast by Country
10.2.3 Asia Pacific Human Rabies Immunoglobulin (IM) Market Size Forecast by Region
10.2.4 South America Human Rabies Immunoglobulin (IM) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Rabies Immunoglobulin (IM) by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Human Rabies Immunoglobulin (IM) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Human Rabies Immunoglobulin (IM) by Type (2025-2030)
11.1.2 Global Human Rabies Immunoglobulin (IM) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Human Rabies Immunoglobulin (IM) by Type (2025-2030)
11.2 Global Human Rabies Immunoglobulin (IM) Market Forecast by Application (2025-2030)
11.2.1 Global Human Rabies Immunoglobulin (IM) Sales (Kilotons) Forecast by Application
11.2.2 Global Human Rabies Immunoglobulin (IM) Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings